Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Technology topic
No spam. Unsubscribe anytime.
Little Seed outlines pediatric-tech work, internships at Hilliard CityLab
Summary
A representative for Little Seed described the company’s use of virtual-reality, augmented-reality and computer-vision tools for pediatric care and said the firm is working with Cincinnati Children’s and using Hilliard’s internship programs.
Just a little seed of an idea can turn into big change, Speaker 1, a representative of Little Seed, said at a presentation at Hilliard CityLab.
Little Seed described itself as a healthcare technology company that develops patient-focused tools using gaming mechanics, virtual reality and augmented reality to help children manage anxiety and to capture movement data through computer vision for clinical measurement. "Connect. Little Seed's a healthcare technology company that works with institutions and inventors to bring novel patient technology solutions to life," Speaker 2, a Hilliard CityLab representative, said.
The company representative said those motion measurements can be used in gene-therapy trials "to see if they're improving, staying the same, or declining." The presentation also noted an ongoing collaboration with Cincinnati Children's on an aromatherapy product; the company said it is "building a specific dispenser and a dispensing method that is designed to help children with anxiety, nausea, other situations," using what the speaker called a "personal grama therapy dispensing device." The transcript did not specify contract terms, funding sources or project timelines.
Speaker 1 also praised the local partnership with the City of Hilliard and noted training opportunities: "City of Hilliard's been amazing as a partner. Being able to actually take advantage of the technology internship programs has been tremendous." The remarks framed the company’s work as multi-step and collaborative, particularly when deployed in hospital settings with vulnerable pediatric patients.
No formal actions, votes or regulatory approvals were recorded in the transcript excerpt. The presentation focused on technology approaches, a collaboration with Cincinnati Children's and use of Hilliard internship programs; it did not include named project budgets, clinical-trial identifiers or implementation schedules.
